Millions of Americans suffer from chronic eye conditions—such as meibomian gland dysfunction (MGD), dry eye, and blepharitis—caused by microorganisms living on their eyelids and lashes. For many years, these microorganisms were almost impossible to manage. Now there is a new weapon called Avenova® that is designed for removal of the microorganisms and debris that contribute to conditions such as MGD, dry eye, and blepharitis.
Interested in our rebate card?
Make sure you take advantage of our Avenova Co-Pay Card. With our savings offer, most eligible patients pay as little as $35 for their Avenova prescription.